Effect of Fuzheng Qingdu Therapy for Metastatic Gastric Cancer is Associated With Improved Survival: A Multicenter Propensity-Matched Study

1. Thrift, A, El-Serag, H. Burden of gastric cancer. Clin Gastroenterol Hepatol. 2020;18:534-542.
Google Scholar | Crossref | Medline2. International Agency for Research on Cancer . World Cancer Report: Cancer Research for Cancer Prevention. International Agency for Research on Cancer. 2021. https://publications.iarc.fr/586
Google Scholar3. Wang, F, Shen, L, Li, J, et al. The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer. Cancer Commun. 2019;39:10.
Google Scholar | Crossref | Medline4. Japanese Gastric Cancer Association . Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1-19.
Google Scholar | Crossref5. Liu, SF, Lu, CR, Cheng, HD, et al. Comparison of therapeutic efficacy between gastrectomy with transarterial chemoembolization plus systemic chemotherapy and systemic chemotherapy alone in gastric cancer with synchronous liver metastasis. Chin Med J. 2015;128:2194-2201.
Google Scholar | Crossref | Medline6. Kang, YK, Chin, K, Chung, HC, et al. S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial. Lancet Oncol. 2020;21:1045-1056.
Google Scholar | Crossref | Medline7. Hung, KF, Hsu, CP, Chiang, JH, et al. Complementary Chinese herbal medicine therapy improves survival of patients with gastric cancer in Taiwan: a nationwide retrospective matched-cohort study. J Ethnopharmacol. 2017;199:168-174.
Google Scholar | Crossref | Medline8. Liu, X, Xiu, LJ, Jiao, JP, et al. Traditional Chinese medicine integrated with chemotherapy for stage IV non-surgical gastric cancer: a retrospective clinical analysis. J Integr Med. 2017;15:469-475.
Google Scholar | Crossref | Medline9. Wu, JR, Liu, SY, Zhu, JL, Zhang, D, Wang, KH. Efficacy of Brucea javanica oil emulsion injection combined with the chemotherapy for treating gastric cancer: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2018;2018:1-10.
Google Scholar | Crossref10. Watanabe, H, Yamamoto, S, Kunitoh, H, et al. Tumor response to chemotherapy: the validity and reproducibility of RECIST guidelines in NSCLC patients. Cancer Sci. 2003;94:1015-1020.
Google Scholar | Crossref | Medline11. Granieri, S, Altomare, M, Bruno, F, et al. Surgical treatment of gastric cancer liver metastases: systematic review and meta-analysis of long-term outcomes and prognostic factors. Crit Rev Oncol Hematol. 2021;163:103313.
Google Scholar | Crossref | Medline12. Luo, HY, Xu, RH, Wang, F, et al. Phase II trial of XELOX as first-line treatment for patients with advanced gastric cancer. Chemotherapy. 2010;56:94-100.
Google Scholar | Crossref | Medline13. He, MM, Wang, F, Jin, Y, et al. Phase II clinical trial of S-1 plus nanoparticle albumin-bound paclitaxel in untreated patients with metastatic gastric cancer. Cancer Sci. 2018;109:3575-3582.
Google Scholar | Crossref | Medline14. Wang, J, Xu, R, Li, J, et al. Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer. Gastric Cancer. 2016;19:234-244.
Google Scholar | Crossref | Medline | ISI15. Liu, X, Li, M, Wang, X, et al. Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma. Phytomedicine. 2019;62:152930.
Google Scholar | Crossref | Medline16. Zhao, X, Dai, X, Wang, S, et al. Traditional Chinese medicine integrated with chemotherapy for stage II-IIIA patients with non-small-cell lung cancer after radical surgery: a retrospective clinical analysis with small sample size. Evid Based Complement Alternat Med. 2018;2018:4369027.
Google Scholar | Crossref | Medline17. Shih, WT, Yang, PR, Shen, YC, Yang, YH, Wu, CY. Traditional Chinese medicine enhances survival in patients with gastric cancer after surgery and adjuvant chemotherapy in Taiwan: a nationwide matched cohort study. Evid Based Complement Alternat Med. 2021;2021:1-8.
Google Scholar | Crossref18. Chen, Y, Zhang, G, Chen, X, et al. Jianpi Bushen, a traditional Chinese medicine therapy, combined with chemotherapy for gastric cancer treatment: a meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2018;2018:1-14.
Google Scholar19. Yang, L, Zhao, L, Zeng, T, et al. Mechanisms underlying therapeutic effects of traditional Chinese medicine On gastric cancer. Cancer Manag Res. 2019;11:8407-8418.
Google Scholar | Crossref | Medline20. Hultman, B, Gunnarsson, U, Nygren, P, Sundbom, M, Glimelius, B, Mahteme, H. Prognostic factors in patients with loco-regionally advanced gastric cancer. World J Surg Oncol. 2017;15:172.
Google Scholar | Crossref | Medline21. Fleischer, T, Chang, TT, Chiang, JH, Sun, MF, Yen, HR. Improved survival with integration of Chinese herbal medicine therapy in patients with acute myeloid leukemia: a nationwide population-based cohort study. Integr Cancer Ther. 2017;16:156-164.
Google Scholar | SAGE Journals | ISI22. Zhou, J, Xing, F, Yan, X, et al. Traditional Chinese medicine master ZHOU Zhong-Ying’s five kinds of methods in anticancer and toxin expelling and his experience in disease differentiation. Chin J Tradit Chin Med Pharm. 2014;29:1112-1114. (in Chinese).
Google Scholar23. Jung, Y, Jerng, U, Lee, S. A systematic review of anticancer effects of radix astragali. Chin J Integr Med. 2016;22:225-236.
Google Scholar | Crossref | Medline24. Hibasami, H, Iwase, H, Yoshioka, K, Takahashi, H. Glycyrrhizin induces apoptosis in human stomach cancer KATO III and human promyelotic leukemia HL-60 cells. Int J Mol Med. 2005;16:233-236.
Google Scholar | Medline25. Zhang, X, Lv, S, Zhang, W, et al. Shenmai injection improves doxorubicin cardiotoxicity via miR-30a/Beclin 1. Biomed Pharmacother. 2021;139:111582.
Google Scholar | Crossref | Medline26. Cheng, L, Liu, W, Zhong, C, et al. Remodeling the homeostasis of pro- and anti-angiogenic factors by Shenmai injection to normalize tumor vasculature for enhanced cancer chemotherapy. J Ethnopharmacol. 2021;270:113770.
Google Scholar | Crossref | Medline27. He, R, Ou, S, Chen, S, Ding, S. Network pharmacology-based study on the molecular biological mechanism of action for compound Kushen injection in anti-cancer effect. Med Sci Monit. 2020;26:e918520.
Google Scholar | Crossref28. Wang, KX, Chen, YP, Lu, AP, et al. A metabolic data-driven systems pharmacology strategy for decoding and validating the mechanism of compound Kushen injection against HCC. J Ethnopharmacol. 2021;274:114043.
Google Scholar | Crossref | Medline29. Lan, HY, An, P, Liu, QP, et al. Aidi injection induces apoptosis of hepatocellular carcinoma cells through the mitochondrial pathway. J Ethnopharmacol. 2021;274:114073.
Google Scholar | Crossref | Medline30. Zhu, M, Liu, X, Zhou, C, Li, J. Effect of sodium cantharidinate/vitamin B6 injection on survival, liver function, immune function, and quality of life in patients with hepatocellular carcinoma: protocol for a meta-analysis. Medicine. 2020;99:e21952.
Google Scholar31. Xu, C, Guo, X, Zhou, C, Zhang, H. Brucea javanica oil emulsion injection (BJOEI) as an adjunctive therapy for patients with advanced colorectal carcinoma: a protocol for a systematic review and meta-analysis. Medicine. 2020;99:e21155.
Google Scholar

留言 (0)

沒有登入
gif